Blog
RSS FeedPosted by Michael Wonder on 23 Jun 2016
UK trailing Europe on access to cancer drugs
23 June 2016 - The UK is trailing Europe on cancer spend, survival rates and patient access to new oncology medicines, ...
Posted by Michael Wonder on 22 Jun 2016
EMA and FDA reinforce collaboration on patient engagement
22 June 2016 - New working group established to exchange best practices. ...
Posted by Michael Wonder on 21 Jun 2016
Santhera’s marketing authorization application for Raxone in Duchenne muscular dystrophy validated by the European Medicines Agency
21 June 2016 - Santhera Pharmaceuticals announces that the EMA has validated its marketing authorization application for Raxone (idebenone) for ...
Posted by Michael Wonder on 20 Jun 2016
Agenda for June 2016 CHMP meeting
20 June 2016 - The agenda for the 20-23 June 2016 CHMP meeting is now available. ...
Posted by Michael Wonder on 20 Jun 2016
EU Council conclusions on strengthening the balance in the pharmaceutical systems in the EU and its Member States
17 June 2016 - The EU wants patients to have access to essential medicines. ...
Posted by Michael Wonder on 20 Jun 2016
‘Brexit’ could relocate EU drug and banking agencies
20 June 2016 - The European Medicines Agency and European Banking Authority are both in London. ...
Posted by Michael Wonder on 16 Jun 2016
EMA publishes list of applications for new human medicines under evaluation by the CHMP
16 June 2016 - This document lists information on applications for centralised marketing authorisation for human medicines that the EMA ...
Posted by Michael Wonder on 16 Jun 2016
Roche’s Gazyvaro approved in Europe in combination with bendamustine for people with previously treated follicular lymphoma
16 June 2016 - This is the second approval in Europe for Gazyvaro based on a positive phase III study. ...
Posted by Michael Wonder on 13 Jun 2016
EMA publishes EPAR for Neparvis (sacubitril with valsartan)
13 June 2016 - The EMA has published an EPAR for Novartis' second brand of sacubitril with valsartan. ...
Posted by Michael Wonder on 10 Jun 2016
EMA celebrates ten years of its patients and consumers working party
10 June 2016 - Join the live broadcast on Tuesday, 14 June from 14:00 to 17:00. ...
Posted by Michael Wonder on 09 Jun 2016
EMA publishes EPAR for Galafold (migalastat hydrochloride)
9 June 2016 - The EMA has published an EPAR for Amicus Therapeutics' Galafold (migalastat hydrochloride). ...
Posted by Michael Wonder on 09 Jun 2016
EMA publishes EPAR for Flixabi (infliximab)
9 June 2016 - The EMA has published an EPAR for Samsung Bioepis' Flixabi (infliximab). ...
Posted by Michael Wonder on 08 Jun 2016
EMA publishes EPAR for autologous CD34+ enriched cell fraction (Strimvelis)
8 June 2016 - The EMA has published an EPAR for autologous CD34+ enriched cell fraction that contains CD34+ cells transduced ...
Posted by Michael Wonder on 08 Jun 2016
Roche receives EU approval of Avastin in combination with Tarceva for patients with a specific type of advanced lung cancer
8 June 2016 - This marks the first approval for Avastin in combination with another targeted therapy. ...
Posted by Michael Wonder on 08 Jun 2016
EU agrees tighter standards for medical devices
1 June 2016 - The European Union has agreed major changes to its 20 year old regulatory framework for medical devices. ...